Neumora Therapeutics, Inc. (NMRA)
0.73
-0.02
(-2.67%)
USD |
NASDAQ |
Sep 18, 16:00
0.7219
-0.01
(-1.11%)
After-Hours: 20:00
Neumora Therapeutics Free Cash Flow : -180.96M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -180.96M |
| March 31, 2026 | -193.40M |
| December 31, 2025 | -206.44M |
| September 30, 2025 | -208.07M |
| June 30, 2025 | -194.90M |
| March 31, 2025 | -198.65M |
| December 31, 2024 | -182.94M |
| September 30, 2024 | -189.45M |
| Date | Value |
|---|---|
| June 30, 2024 | -203.77M |
| March 31, 2024 | -178.64M |
| December 31, 2023 | -167.98M |
| September 30, 2023 | -142.30M |
| June 30, 2023 | -120.38M |
| March 31, 2023 | -116.12M |
| December 31, 2022 | -128.41M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioAge Labs, Inc. | -88.09M |
| LB Pharmaceuticals, Inc. | -82.83M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -39.97M |
| Cash from Financing (Quarterly) | 9.735M |
| Free Cash Flow Per Share (Quarterly) | -0.2159 |
| Free Cash Flow to Equity (Quarterly) | -39.85M |
| Free Cash Flow to Firm (Quarterly) | -38.15M |
| Free Cash Flow Yield | -142.6% |